$120.94
0.200.17%
In chiusura: -
$120.99
0.050.04%
After hour: 4:06 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Gilead Sciences. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Gilead Sciences.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Gilead Sciences Inc addetti ai lavori?
A Gilead Sciences Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 15.50K azioni del valore di $1.77M, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno settembre 16, 2025, Andrew D Dickinson, l'azienda CHIEF FINANCIAL OFFICER sold 2.5K condivisioni per $113.57 ciascuna.
- Il giorno ottobre 16, 2025, Andrew D Dickinson, l'azienda CHIEF FINANCIAL OFFICER sold 2.5K condivisioni per $118.08 ciascuna.
- Il giorno agosto 18, 2025, Andrew D Dickinson, l'azienda CHIEF FINANCIAL OFFICER sold 2.5K condivisioni per $118.53 ciascuna.
Statistiche sulla proprietà per Gilead Sciences Inc
Numero di azioni emesse
1.241B
Azioni possedute dagli insider
8.614M
Percentuale posseduta dagli Insider
0.69%
Azioni possedute dagli investitori istituzionali
838.397M
Percentuale posseduta dagli investitori istituzionali
67.6%
Oct 16, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $118.08 | -$295.20K | SELL | -1.57% | 157.06K | Oct 15 | ||
Oct 16, 2025 | CHIEF COMMERCIAL OFFICER | -3.00K | $118.08 | -$354.24K | SELL | -2.65% | 110.19K | Oct 15 | ||
Sep 30, 2025 | CHAIRMAN & CEO | -10.00K | $111.66 | -$1.12M | SELL | -1.66% | 591.20K | Sep 29 | ||
Sep 16, 2025 | CHIEF COMMERCIAL OFFICER | -3.00K | $113.57 | -$340.71K | SELL | -2.58% | 113.19K | Sep 15 | ||
Sep 16, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $113.57 | -$283.93K | SELL | -1.54% | 159.56K | Sep 15 | ||
Aug 29, 2025 | CHAIRMAN & CEO | -10.00K | $113.63 | -$1.14M | SELL | -1.65% | 595.73K | Aug 28 | ||
Aug 18, 2025 | CHIEF COMMERCIAL OFFICER | -3.00K | $92.59 | -$1.65M | SELL | -2.56% | 114.17K | Aug 15 | ||
Aug 18, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $118.53 | -$296.32K | SELL | -1.54% | 160.11K | Aug 15 | ||
Jul 29, 2025 | CHAIRMAN & CEO | -10.00K | $113.94 | -$1.14M | SELL | -1.62% | 605.73K | Jul 28 | ||
Jul 16, 2025 | CHIEF COMMERCIAL OFFICER | -3.00K | $111.03 | -$333.09K | SELL | -2.50% | 117.17K | Jul 15 | ||
Jul 16, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $111.03 | -$277.57K | SELL | -1.51% | 162.61K | Jul 15 | ||
Jul 15, 2025 | DIRECTOR | 0.00 | $88.59 | -$211.45K | SELL-OPTIONS | 0.00% | 8.92K | Jul 14 | ||
Jul 01, 2025 | CHAIRMAN & CEO | -10.00K | $110.45 | -$1.10M | SELL | -1.60% | 615.73K | Jun 30 | ||
Jun 17, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $110.17 | -$275.43K | SELL | -1.49% | 165.11K | Jun 16 | ||
Jun 17, 2025 | CHIEF COMMERCIAL OFFICER | -3.00K | $110.17 | -$330.51K | SELL | -2.44% | 120.17K | Jun 16 | ||
Jun 02, 2025 | CHAIRMAN & CEO | -10.00K | $110.42 | -$1.10M | SELL | -1.59% | 620.27K | May 30 | ||
May 23, 2025 | CHIEF COMMERCIAL OFFICER | -3.00K | $87.08 | -$1.34M | SELL | -2.42% | 121.15K | May 22 | ||
May 16, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $99.82 | -$249.55K | SELL | -1.49% | 165.67K | May 15 | ||
Apr 16, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $106.40 | -$266.00K | SELL | -1.46% | 168.17K | Apr 15 | ||
Mar 18, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $110.53 | -$276.32K | SELL | -1.44% | 170.67K | Mar 17 | ||
Mar 12, 2025 | CHIEF FINANCIAL OFFICER | 4.11K | $90.96 | -$1.42M | SELL-OPTIONS | 2.43% | 173.17K | Mar 10 | ||
Feb 19, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $104.09 | -$260.23K | SELL | -1.46% | 169.06K | Feb 18 | ||
Feb 13, 2025 | CHIEF FINANCIAL OFFICER | 0.00 | $84.74 | -$4.81M | SELL-OPTIONS | 0.00% | 171.22K | Feb 12 | ||
Feb 03, 2025 | CHIEF FINANCIAL OFFICER | 0.00 | $82.37 | -$4.22M | SELL-OPTIONS | 0.00% | 129.87K | Jan 31 | ||
Jan 16, 2025 | CHIEF FINANCIAL OFFICER | -2.50K | $91.35 | -$228.38K | SELL | -1.89% | 129.87K | Jan 15 | ||
Dec 17, 2024 | CHIEF FINANCIAL OFFICER | -8.50K | $91.96 | -$781.66K | SELL | -6.03% | 132.37K | Dec 16 | ||
Dec 03, 2024 | CHIEF FINANCIAL OFFICER | 0.00 | $81.63 | -$5.54M | SELL-OPTIONS | 0.00% | 138.92K | Nov 29 | ||
Nov 29, 2024 | CHIEF MEDICAL OFFICER | -18.80K | $77.18 | -$6.01M | SELL | -18.87% | 80.80K | Nov 27 | ||
Nov 27, 2024 | DIRECTOR | 3.21K | $76.32 | -$7.91K | SELL-OPTIONS | 56.27% | 8.92K | Nov 26 | ||
Nov 07, 2024 | CHIEF COMMERCIAL OFFICER | -5.00K | $91.28 | -$456.40K | SELL | -6.40% | 73.13K | Nov 06 | ||
Nov 07, 2024 | CHIEF MEDICAL OFFICER | -590.00 | $74.71 | -$893.49K | SELL | -0.59% | 99.60K | Nov 06 | ||
Oct 02, 2024 | CHIEF MEDICAL OFFICER | -2.00K | $83.83 | -$167.66K | SELL | -1.96% | 100.19K | Oct 01 | ||
Sep 13, 2024 | CHIEF MEDICAL OFFICER | 3.75K | $71.21 | -$347.29K | SELL-OPTIONS | 3.81% | 102.19K | Sep 12 | ||
Sep 13, 2024 | CHIEF COMMERCIAL OFFICER | -29.36K | $83.78 | -$2.46M | SELL | -27.31% | 78.13K | Sep 12 | ||
Aug 29, 2024 | CHIEF COMMERCIAL OFFICER | -9.51K | $78.03 | -$742.30K | SELL | -8.27% | 105.47K | Aug 28 | ||
Aug 14, 2024 | CHIEF COMMERCIAL OFFICER | -5.49K | $73.98 | -$406.15K | SELL | -4.56% | 114.98K | Aug 13 | ||
Jul 01, 2024 | CHIEF MEDICAL OFFICER | -2.00K | $68.63 | -$137.26K | SELL | -2.03% | 96.38K | Jul 01 | ||
Apr 02, 2024 | CHIEF MEDICAL OFFICER | -2.00K | $72.96 | -$145.92K | SELL | -2.03% | 96.30K | Apr 01 | ||
Feb 29, 2024 | CHIEF MEDICAL OFFICER | -10.23K | $72.82 | -$744.98K | SELL | -9.94% | 92.71K | Feb 28 - Feb 29 | ||
Jan 17, 2024 | CHIEF FINANCIAL OFFICER | -5.00K | $85.78 | -$428.90K | SELL | -4.69% | 101.53K | Jan 16 | ||
Jan 10, 2024 | CHIEF COMMERCIAL OFFICER | -8.24K | $85.23 | -$702.47K | SELL | -9.06% | 82.73K | Jan 09 | ||
Oct 18, 2023 | CHIEF FINANCIAL OFFICER | -5.00K | $80.00 | -$400.02K | SELL | -4.59% | 104.00K | Oct 17 | ||
Sep 13, 2023 | CHIEF MEDICAL OFFICER | -1.50K | $76.99 | -$115.56K | SELL | -2.10% | 70.13K | Sep 12 | ||
Jul 21, 2023 | CHIEF FINANCIAL OFFICER | -5.00K | $80.00 | -$400.00K | SELL | -4.44% | 107.59K | Jul 20 | ||
Jun 14, 2023 | CHIEF MEDICAL OFFICER | -1.49K | $76.90 | -$114.20K | SELL | -4.81% | 29.40K | Jun 13 | ||
Mar 14, 2023 | CHIEF MEDICAL OFFICER | -6.13K | $78.99 | -$483.89K | SELL | -8.03% | 70.13K | Mar 13 | ||
Mar 02, 2023 | CHIEF MEDICAL OFFICER | -12.98K | $79.96 | -$1.04M | SELL | -15.62% | 70.13K | Mar 01 | ||
Jan 03, 2023 | CHIEF MEDICAL OFFICER | -553.00 | $85.33 | -$47.19K | SELL | -1.20% | 45.56K | Dec 30 | ||
Nov 10, 2022 | SVP, CONTROLLER & CAO | 0.00 | $73.70 | -$125.69K | SELL-OPTIONS | 0.00% | 28.33K | Nov 09 | ||
Nov 02, 2022 | SVP, CONTROLLER & CAO | 0.00 | $75.97 | -$106.47K | SELL-OPTIONS | 0.00% | 28.33K | Nov 01 | ||
Mar 14, 2022 | EVP,CORP AFFAIRS & GEN COUNSEL | 0.00 | $58.12 | -$332.64K | SELL-OPTIONS | 0.00% | 32.58K | Mar 10 - Mar 11 | ||
Feb 11, 2022 | EVP,CORP AFFAIRS & GEN COUNSEL | -1.69K | $63.89 | -$108.04K | SELL | -4.93% | 32.58K | Feb 09 | ||
Feb 02, 2022 | EVP,CORP AFFAIRS & GEN COUNSEL | -14.06K | $68.54 | -$963.68K | SELL | -30.15% | 32.58K | Feb 01 | ||
Aug 18, 2021 | SVP, CONTROLLER & CAO | 0.00 | $70.29 | -$60.19K | SELL-OPTIONS | 0.00% | 20.40K | Aug 17 | ||
May 05, 2021 | CHIEF COMMERCIAL OFFICER | -19.50K | $66.09 | -$1.29M | SELL | -70.73% | 8.07K | May 04 | ||
May 04, 2021 | DIRECTOR | 0.00 | $42.61 | -$890.93K | SELL-OPTIONS | 0.00% | 31.12K | May 03 | ||
Mar 12, 2021 | EVP,CORP AFFAIRS & GEN COUNSEL | 334.00 | $60.23 | -$145.91K | SELL-OPTIONS | 1.16% | 29.17K | Feb 15 - Mar 11 | ||
Feb 11, 2021 | EVP,CORP AFFAIRS & GEN COUNSEL | -1.98K | $67.41 | -$133.13K | SELL | -6.41% | 28.83K | Feb 10 | ||
Feb 03, 2021 | EVP,CORP AFFAIRS & GEN COUNSEL | -9.71K | $65.97 | -$640.63K | SELL | -25.20% | 28.83K | Feb 01 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.